Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,209,294
New position
Shares Held
6,101
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,226
of 3,140 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LGT Fund Management Co Ltd. holds $166,987,121 across 7 Drug Manufacturers - General names. AMGN ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
58,755 | $70,472,515 | |
| 2 | JNJ |
Johnson & Johnson
|
116,198 | $29,510,806 | |
| 3 | AZN |
Astrazeneca PLC
|
139,758 | $26,500,911 | |
| 4 | PFE |
Pfizer Inc
|
857,783 | $20,655,414 | |
| 5 | ABBV |
AbbVie Inc.
|
49,911 | $12,559,604 | |
| 6 | MRK |
Merck & Co., Inc.
|
39,522 | $5,078,577 | |
| 7 | AMGN |
Amgen Inc
This page
|
6,101 | $2,209,294 |
All Filings in AMGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,209,294 | 6,101 | Shares | Defined | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||